Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Facility Certification and Inspection (MQSA)

Facility Certification and Inspection (MQSA)

                        Mammography Safety Notifications
          Inspection News
          Digital Accreditation
          Facilities - Mammography Quality Standards Act Requirements
          Facility Certification and Inspection Mammography Quality Standards Act (MQSA): Inspection Fees
          MQSA:  Accreditation Bodies
          Residency Letter for Residency Graduates of 2014 or Later
          Facility Certification and Inspection: CMS Reimbursement Issues
          Inspection Procedures
          Preparing for an Inspection
          Revised MQSA Policy on Follow Up for Inspection Violations Home
          Radiation-Emitting Products
          Mammography Quality Standards Act and Program
          Facility Certification and Inspection (MQSA)
          Facility Certification and Inspection Mammography Quality Standards Act (MQSA): Inspection FeesFacility Certification and Inspection (MQSA) Facility Certification and Inspection Mammography Quality Standards Act (MQSA): Inspection Fees
  
  	
    Share
    Post
    Linkedin

    Email
    PrintThe FDA Mammography Quality Standards Act (MQSA) inspection fee for a mammography facility with one unit is $2,150 effective October 1, 2007. The charge for each additional unit is $250. The fee for a follow-up inspection is $1,144. Facilities in certifying states (Illinois, Iowa, South Carolina and Texas) should contact their state certifying agency to determine the fees that apply to them. The FDA portion of the fee for facilities within approved certifying states is $548.

**Legislative Authority**

The Mammography Quality Standards Act (MQSA) of 1992 and the subsequent reauthorization Acts require the FDA to assess and collect fees from mammography facilities to cover the costs of inspections.

**Federal Register Notice**

FDA revised the following inspection fee structure under MQSA as explained in the July 6, 2007 Federal Register (FR) Notice (72 FR 37027)

Number of Units
			Fee1
			$2,1502
			$2,4003
			$2,6504
			$2,9005
			$3,1506
			$3,4007
			$3,6508
			$3,9009
			$4,15010
			$4,400Follow-up Inspection Fee
			$1,144 (if subject to fees)Facilities Operating Within Approved Certifying States
			$548

Inspection Fee Payment: Government Entity (GE) Status Facilities

(1) A governmental entity is a mammography facility subject to inspection under section 354 (g)(1) of the Public Health Service Act, 42 U.S.C. 263b(g)(1) that meets either of the following criteria: (1) The facility is operated by any federal department, state, district, territory, possession, federally-recognized Indian tribe, city, county, town, village, municipal corporation or similar political organization or subpart thereof. The entire salary of all on-site personnel of the mammography facility must be directly paid by a particular form of government as listed above. All the facility's mammography equipment must be owned, rented by, or leased by a particular from of government as listed above. The facility's ultimate authority to make day-to-day decisions concerning the management and operation of the mammography facility must come from a particular form of government as listed above. All these requirements must be met in order for a facility to be considered a governmental entity. The particular form of government also must be listed on the Governmental Entity Declaration form (Form 3422) [PDF] in the space provided. FDA does not recognize a facility providing Medicare/Medicaid services without meeting the governmental entity criteria described above.

(2) The facility provides services under the Centers for Disease Control and Prevention (CDC) grant supporting the Breast and Cervical Cancer Mortality Prevention Act of 1990 and at least 50% of the mammography screening examinations provided during the preceding 12 months were funded under that statute. The FDA does not recognize other breast cancer or mammography programs/grants under the governmental entity exemption.

Following the closure of the FDA MQSA inspection, the FDA issues an invoice and includes the Government Entity (GE) Declaration form mentioned above. If your facility fulfills the Government Entity (GE) criteria, please complete the form and return within 30 days of receipt of your MQSA inspectional invoice to the following address:

**FDA FORM 3422 (GE):  If your facility is claiming GE status, please complete the GE Declaration form (Form 3422) Government Entity Declaration (PDF) and submit it electronically to MQSAUserFeeSupport@fda.hhs.gov.**

If the FDA accepts your facility as a governmental entity, you will not receive additional fee statements concerning the inspection. If you continue to receive fee statements, however, please contact the MQSA Hotline by one of the options outlined below to discuss the status of your claim.

NOTE: Facilities claiming governmental entity status must submit a governmental entity form each year. The FDA conducts a Governmental Entity Audit periodically. Your facility may be selected as part of an audit sample. If your facility is selected to participate in the audit, your facility may be notified to provide additional information substantiating your GE claim.

MQSA 2024 Governmental Entity (GE) Audit Results

In January 2024, the U.S. Food and Drug Administration (FDA) will begin its Governmental Entity (GE) audit of certified mammography facilities that claim the exemption under the Mammography Quality Standards Act (MQSA). The MQSA requires that mammography facilities submit an annual self-certification form (Form FDA 3422) to claim GE status.  The annual mammography inspection fees are waived for facilities with a GE exemption status.

To verify these claims, the FDA has randomly selected a sample of mammography facilities claiming GE status, between the dates of October 1, 2022 through September 30, 2023, to participate in this audit. The FDA will contact these facilities via email to advise them of the steps they need to take to verify their GE exemption status.

Inspection Fees: Non-Governmental Entity (GE) Status Facilities

If your facility is not eligible to apply for GE status under MQSA, you must pay your inspection fee within 30 days from the date of the invoice, issued following the closure of your MQSA inspection.

You can pay online at https://userfees.fda.gov/pay. (Note: Only full payments are accepted. No partial payments can be made online.)  You may also pay your inspection fees through the U.S. Postal Service. Payment in the form of United States (U.S.) dollars by check, bank draft, or U.S. Postal Order drawn on or payable through a U.S. financial institution is accepted. Please make your payment to the order of the FDA MQSA Program and mail it through the U.S. Postal Service within the above-specified time frame to the following address:

Food and Drug Administration
P.O. Box 979109
St. Louis, MO 63197-9000

For Overnight Courier Address:

U.S. Bank ATTN: Government Lockbox 979109
1005 Convention Plaza
St. Louis, MO 63101

Non-Payment of Inspection Fee

If the FDA does not receive FULL payment within 30 days from the date of the invoice, your facility will be subject to the provisions of the Department of Health and Human Services (DHHS) Claims Collection Regulations at Section 30.13 of Title 45 of the Code of Federal Regulations (45 CFR 30.13). The Regulations give the FDA the authority to assess an interest penalty at the prevailing rate set by the Department of Treasury, subject to change on a quarterly basis (currently 9.75% APR); assess a $20 administrative fee for delinquent invoices over $100 for each full 30-day period the account remains outstanding; and assess a late penalty payment (6% per year).

Also, the FDA will take one or more of the following actions if you do not pay your inspection fee in FULL within 30 days of the invoice date:

Report this debt to credit reporting agencies.
	Forward your account to a collection agency and/or the U.S. Department of Treasury (DOT) for enforced collection and credit bureau reporting, in accordance with the Debt Collection Act of 1982 and the Debt Collection Improvement Act of 1996 if you continue to be delinquent in paying this fee.
	Forward your account to the DOT, Treasury Offset Program (TOP), which offsets your Federal payments, including any tax refund due you from the Internal Revenue Service (IRS), to collect your delinquent debt.
	Refer your account to the Department of Justice (DOJ) for appropriate action, or to the IRS for reporting of additional income.**Note: All additional fees charged by these entities will be the responsibility of the facility (ranging from 3% to 28% of the total amount due).**

Inspection Fee Consolidation

Providers with multiple mobile mammography units and some stationary sites operating under two or more MQSA certificates may have the option (for inspection purposes only) of combining their facilities to reduce their total inspection fee (Total Inspection Fee = $2,150 + n-1 x $250 where n = total number of units inspected). Discuss your eligibility for inspection fee consolidation with your MQSA inspector prior to the inspection. More information regarding inspection fee consolidation is available in the MQSA Inspection Procedures.

Changes to Facility Information

Billing Specific Changes:

If the billing email address we used to email your fee statement is incorrect, please contact the MQSAUserFeeSupport@fda.hhs.gov.Other Facility Changes (for example, official contact or address, EIN# and unit information):

Please confirm your accreditation body has updated and correct information from your facility. The FDA provides facility information from accreditation body’s to the Centers for Medicare and Medicaid Services. Incorrect information may result in reimbursement delays or denials.Inspection Fee Questions

If you have any questions about MQSA Inspection Fees or GE declaration you may contact MQSAUserFeeSupport@fda.hhs.gov.

If you have questions regarding MQSA certification, you may contact the MQSA Hotline at 1-800-838-7715 or by email MQSAhotline@versatechinc.com.

                                                                                  Content current as of:
      12/20/2023Facility Certification and Inspection (MQSA)

          
                        Mammography Safety Notifications
          Inspection News
          Digital Accreditation
          Facilities - Mammography Quality Standards Act Requirements
          Facility Certification and Inspection Mammography Quality Standards Act (MQSA): Inspection Fees
          MQSA:  Accreditation Bodies
          Residency Letter for Residency Graduates of 2014 or Later
          Facility Certification and Inspection: CMS Reimbursement Issues
          Inspection Procedures
          Preparing for an Inspection
          Revised MQSA Policy on Follow Up for Inspection Violations
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop